Kai M, Iida H, Nohta H, Lee M K, Ohta K
School of Pharmaceutical Sciences, Nagasaki University, Japan.
J Chromatogr B Biomed Sci Appl. 1998 Dec 11;720(1-2):25-31. doi: 10.1016/s0378-4347(98)00420-4.
A pre-column derivatization method using a fluorogenic reagent, 1,2-diphenylethylenediamine (DPE) was studied for the sensitive HPLC determination of 5-hydroxytryptamine (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA), which are biosubstances used in the diagnosis of several diseases. For the quantitative determination, the biogenic indole compounds were converted to their corresponding fluorescent derivatives with DPE in the presence of potassium hexacyanoferrate (III) at room temperature, and then the derivatives were separated by reversed-phase liquid chromatography with fluorescence detection. The chromatographic detection limits of the fluorescent peaks at a signal-to-noise ratio of 3 were 0.3 fmol for 5-HT and 0.2 fmol for 5-HIAA. The proposed method permits the simultaneous quantification of 5-HT and 5-HIAA at concentrations higher than 2.4 nM in human urine without a clean-up procedure.
研究了一种使用荧光试剂1,2 - 二苯基乙二胺(DPE)的柱前衍生化方法,用于灵敏地高效液相色谱测定5 - 羟色胺(5 - HT)和5 - 羟基吲哚乙酸(5 - HIAA),这两种生物物质用于多种疾病的诊断。为进行定量测定,在室温下,生物源性吲哚化合物在铁氰化钾(III)存在下与DPE反应转化为相应的荧光衍生物,然后通过反相液相色谱结合荧光检测对衍生物进行分离。在信噪比为3时,5 - HT荧光峰的色谱检测限为0.3 fmol,5 - HIAA为0.2 fmol。所提出的方法无需净化程序即可同时定量测定人尿中浓度高于2.4 nM的5 - HT和5 - HIAA。